Yesterday, Dr. Reddys Laboratories was listed as an index component of the Dow Jones Sustainability Indices 2016 in the pharmaceuticals, biotechnology and life sciences industry group. The company has been identified for its corporate sustainability leadership and is the lone pharmaceutical company on the index of emerging markets. On the previous trading day, Dr. Reddys share price had closed on a red note, and the market is yet to react to the achievement of the company.
The listing was done based on 22 measures, with Dr. Reddys receiving high scores on product quality and recall management, environmental reporting, corporate citizenship, and philanthropy.
G V Prasad, co-chairman, and CEO of Dr. Reddy's said that over the years, Dr. Reddy's has unfolded into a global organization, built on the foundation of responsible business practices. This has earned them the trust and respect of all the stakeholders they serve. The company sees its inclusion in the Dow Jones Sustainability Indices as another confirmation of their commitment to sustainability in all aspects of our business.
In the last trading session on Monday, 12th September, Dr. Reddys share price had closed at Rs. 3137.60 and it is yet to be seen that if the scrip opens green today.
The Dow Jones Sustainability Indices is a leading global benchmark for corporate sustainability.
DJSI keeps a track on the leading sustainability-driven companies depending on the analysis of financially relevant environmental, social and governance factors.
Dr. Reddys is the top 500 pick by Dynamic Levels for the quarter. For the resistance and support levels of the stock, visit Dr. Reddys share price forecast page of Dynamic Levels website.
No comments:
Post a Comment